Applied Molecular Transport Inc.
(NASDAQ CM: AMTI)
Rigrodsky Law, P.A. is investigating Applied Molecular Transport Inc. (“Applied Molecular”) regarding possible breaches of fiduciary duties and other violations of law related to Cambridge’s agreement to be acquired by Cyclo Therapeutics, Inc. (“Cyclo”). Under the terms of the agreement, Applied Molecular shareholders will receive 0.174 shares of Cyclo’s common stock for each share of Applied Molecular common stock owned.